Resona Asset Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
Other funds holding CRL
AI
Resona Asset Management's CRL Position: Q2 2026 in Review
Resona Asset Management increased its Charles River Laboratories (CRL) stake by 22% in Q2 2026, buying an estimated $22.6K and bringing the position to 711 shares worth $160K. The position accounts for ﹤0.01% of the portfolio, ranked #744.
Resona Asset Management first reported a position in CRL in Q1 2024 and has held it in 10 quarters since. The position peaked at $4.55M in Q1 2024. 563 funds tracked by Wall St. Rank hold CRL as of Q2 2026.
- Resona Asset Management held 711 shares of Charles River Laboratories worth $160K as of Q2 2026.
- Resona Asset Management bought 127 Charles River Laboratories shares in Q2 2026, an estimated $22.6K.
- Charles River Laboratories made up ﹤0.01% of Resona Asset Management's portfolio in Q2 2026, its #744 holding.
- Resona Asset Management first reported a position in Charles River Laboratories in Q1 2024 and has held it in 10 quarters since.
- Resona Asset Management's Charles River Laboratories position peaked at $4.55M in Q1 2024.
- 563 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.
Based on Resona Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.